Find clinical trials for COVID-19 in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Paris, Île-de-France, FRA:
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Paris, France and 100 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Créteil, Ile-de-France, France and 66 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Paris, Île-de-France Region, France and 215 other locations
One of the current health challenges in the face of the COVID-19 pandemic that started in Wuhan in 2019, and still responsible for ...
Paris, France
The purpose of this post-market clinical investigation is to assess in a real-life setting, the effectiveness, usage, tolerance, safety and satisfact...
Bourg-la-Reine, France and 31 other locations
Currently, there is no approved treatment for COVID-19 in France, either for the acute phase, nor for the late chronic phase. the i...
Phase 3
Paris, France
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Créteil, France and 446 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...
Phase 3
Paris, Paris, France and 246 other locations
Globally, women accounted for more than half of people living with HIV (53%) in 2022. In France, 54% of new infections were heterosexual in 2022, 71%...
Paris, France and 1 other location
This is a French multicenter open label non-randomized Phase II trial evaluating the efficacy and tolerance of a combination of oral zanubrutinib and...
Phase 2
Paris, France and 36 other locations
Clinical trials
Research sites
Resources
Legal